
    
      The study wants to define the maximum tolerated dose (MTD) of a conformal short course
      accelerated radiation therapy delivered in twice daily fractions and 2 consecutive days, and
      the feasibility of this fractionation in term of safety and efficacy for symptomatic
      palliation of metastatic or locally advanced head and neck cancer.
    
  